Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.SummaryDifference0.7%

- Check30 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page continues to show the ClinicalTrials.gov record history for the pediatric lanadelumab study, including its submitted versions and the sections changed in each version.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.7.0 is added to the history, and the older revision v3.6.6 is removed. This reflects an update to the study page's revision history rather than any change to study content.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.